EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Drug Repurposing Against Sarscov2 Tabish Qidwai

Name: Drug Repurposing Against Sarscov2 Tabish Qidwai
SKU: BELL-50334796
Price: 31.00 USD
Availability: InStock
Rating: 5 (108 reviews)

SKU: BELL-50334796

$ 31.00 ~~$ 45.00~~ (-31%)

5.0

108 reviews

Drug Repurposing Against Sarscov2 Tabish Qidwai instant download after payment.

Publisher: Bentham Science Publishers

File Extension: PDF

File size: 36.01 MB

Pages: 204

Author: Tabish Qidwai

ISBN: 9789815123203, 9815123203

Language: English

Year: 2023

Product desciption

Drug Repurposing Against Sarscov2 Tabish Qidwai by Tabish Qidwai 9789815123203, 9815123203 instant download after payment.

Drug repurposing is a cost-effective method of discovering new treatments for diseases than traditional drug development methods. It involves virtual screening of chemical candidates with the aid of computational methods like molecular docking.
Drug Repurposing against SARS-CoV2 focuses on current trends in drug repurposing against the novel coronavirus strains. The book aims to give readers an overview of drug repurposing against COVID-19 and various techniques involved in the process. The book consolidates available information on the pathophysiology, drug targets, and drug repurposing against COVID-19 into a single, convenient resource.
Key features
• An up-to-date compilation of the evidence that supports the drug repurposing for COVID-19.
• How to use repurposing of available drugs for disease therapy.
• Provides an improved understanding of pathophysiology and SARS-CoV2 viral entry pathways.
• Provides references for further reading